This patent covers the isolation of neural stem cells, primarily from human fetal origin. These stem cells are purified by 2 steps. First the fetal cells are bound to the antibody 8G1 and then they are further purified for expression of AC133 and 5E12.
This patent is similar to several others from the same family such as Patent # 7,153,686 Compositions of enriched central nervous system stem cell and progenitor cell populations and Patent # 7037719 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.